| Symbol |
Name |
|
AASDH
|
aminoadipate-semialdehyde dehydrogenase
|
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABHD6
|
abhydrolase domain containing 6
|
|
ABI3BP
|
ABI family, member 3 (NESH) binding protein
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAT1
|
acetyl-CoA acetyltransferase 1
|
|
ACD
|
adrenocortical dysplasia homolog (mouse)
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACLY
|
ATP citrate lyase
|
|
ACO1
|
aconitase 1, soluble
|
|
ACOX3
|
acyl-CoA oxidase 3, pristanoyl
|
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVR1
|
activin A receptor, type I
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADAMTS10
|
ADAM metallopeptidase with thrombospondin type 1 motif, 10
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9
|
|
ADAP1
|
ArfGAP with dual PH domains 1
|
|
ADARB1
|
adenosine deaminase, RNA-specific, B1
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADGRB1
|
adhesion G protein-coupled receptor B1
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADPGK
|
ADP-dependent glucokinase
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AEBP1
|
AE binding protein 1
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGR2
|
anterior gradient 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIM2
|
absent in melanoma 2
|
|
AIPL1
|
aryl hydrocarbon receptor interacting protein-like 1
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPI
|
alkaline phosphatase, intestinal
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMER2
|
APC membrane recruitment protein 2
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANP32C
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member C
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
ANXA5
|
annexin A5
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC3
|
apolipoprotein C-III
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AQP4
|
aquaporin 4
|
|
AQP5
|
aquaporin 5
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
|
|
AREG
|
amphiregulin
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
ARHGAP21
|
Rho GTPase activating protein 21
|
|
ARHGAP29
|
Rho GTPase activating protein 29
|
|
ARHGEF15
|
Rho guanine nucleotide exchange factor (GEF) 15
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa
|
|
ARSA
|
arylsulfatase A
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASH2L
|
ash2 (absent, small, or homeotic)-like (Drosophila)
|
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
ASPH
|
aspartate beta-hydroxylase
|
|
ATF2
|
activating transcription factor 2
|
|
ATF4
|
activating transcription factor 4
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATN1
|
atrophin 1
|
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
ATXN3
|
ataxin 3
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AUTS2
|
autism susceptibility candidate 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
B2M
|
beta-2-microglobulin
|
|
B3GNT5
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5
|
|
B3GNT8
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8
|
|
B4GALNT1
|
beta-1,4-N-acetyl-galactosaminyl transferase 1
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BATF2
|
basic leucine zipper transcription factor, ATF-like 2
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCAR3
|
breast cancer anti-estrogen resistance 3
|
|
BCAR4
|
breast cancer anti-estrogen resistance 4 (non-protein coding)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L2
|
BCL2-like 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDH1
|
3-hydroxybutyrate dehydrogenase, type 1
|
|
BDH2
|
3-hydroxybutyrate dehydrogenase, type 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEX2
|
brain expressed X-linked 2
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIN1
|
bridging integrator 1
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP5
|
bone morphogenetic protein 5
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BNIP3L
|
BCL2/adenovirus E1B 19kDa interacting protein 3-like
|
|
BPIFA4P
|
BPI fold containing family A, member 4, pseudogene
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRAP
|
BRCA1 associated protein
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD4
|
bromodomain containing 4
|
|
BRE
|
brain and reproductive organ-expressed (TNFRSF1A modulator)
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BSG
|
basigin (Ok blood group)
|
|
BTG2
|
BTG family, member 2
|
|
C14ORF1
|
chromosome 14 open reading frame 1
|
|
C1GALT1C1
|
C1GALT1-specific chaperone 1
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C5
|
complement component 5
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
|
CACNA2D3
|
calcium channel, voltage-dependent, alpha 2/delta subunit 3
|
|
CADM1
|
cell adhesion molecule 1
|
|
CAGE1
|
cancer antigen 1
|
|
CALB2
|
calbindin 2
|
|
CALR
|
calreticulin
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCDC26
|
CCDC26 long non-coding RNA
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA1
|
cyclin A1
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNT1
|
cyclin T1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD19
|
CD19 molecule
|
|
CD1D
|
CD1d molecule
|
|
CD209
|
CD209 molecule
|
|
CD226
|
CD226 molecule
|
|
CD24
|
CD24 molecule
|
|
CD247
|
CD247 molecule
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD28
|
CD28 molecule
|
|
CD300LF
|
CD300 molecule-like family member f
|
|
CD302
|
CD302 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD70
|
CD70 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD81
|
CD81 molecule
|
|
CD82
|
CD82 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC42
|
cell division cycle 42
|
|
CDC7
|
cell division cycle 7
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK16
|
cyclin-dependent kinase 16
|
|
CDK3
|
cyclin-dependent kinase 3
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK8
|
cyclin-dependent kinase 8
|
|
CDKL3
|
cyclin-dependent kinase-like 3
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDX1
|
caudal type homeobox 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CELF1
|
CUGBP, Elav-like family member 1
|
|
CENPH
|
centromere protein H
|
|
CES2
|
carboxylesterase 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHD1L
|
chromodomain helicase DNA binding protein 1-like
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHKA
|
choline kinase alpha
|
|
CHMP3
|
charged multivesicular body protein 3
|
|
CHP2
|
calcineurin-like EF-hand protein 2
|
|
CHPT1
|
choline phosphotransferase 1
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLDN1
|
claudin 1
|
|
CLDN6
|
claudin 6
|
|
CLDN9
|
claudin 9
|
|
CLIC1
|
chloride intracellular channel 1
|
|
CLSPN
|
claspin
|
|
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5
|
|
CNDP2
|
CNDP dipeptidase 2 (metallopeptidase M20 family)
|
|
CNKSR1
|
connector enhancer of kinase suppressor of Ras 1
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COIL
|
coilin
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL9A1
|
collagen, type IX, alpha 1
|
|
COMMD1
|
copper metabolism (Murr1) domain containing 1
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
COX15
|
cytochrome c oxidase assembly homolog 15 (yeast)
|
|
CRABP1
|
cellular retinoic acid binding protein 1
|
|
CRBN
|
cereblon
|
|
CREB3L4
|
cAMP responsive element binding protein 3-like 4
|
|
CREBZF
|
CREB/ATF bZIP transcription factor
|
|
CRIP2
|
cysteine-rich protein 2
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSMD1
|
CUB and Sushi multiple domains 1
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CST6
|
cystatin E/M
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTBP2
|
C-terminal binding protein 2
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTCFL
|
CCCTC-binding factor (zinc finger protein)-like
|
|
CTH
|
cystathionine gamma-lyase
|
|
CTHRC1
|
collagen triple helix repeat containing 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSL
|
cathepsin L
|
|
CUL4B
|
cullin 4B
|
|
CUL5
|
cullin 5
|
|
CUX1
|
cut-like homeobox 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYSLTR2
|
cysteinyl leukotriene receptor 2
|
|
DAB2IP
|
DAB2 interacting protein
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAXX
|
death-domain associated protein
|
|
DBNL
|
drebrin-like
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCK
|
deoxycytidine kinase
|
|
DCN
|
decorin
|
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDT
|
D-dopachrome tautomerase
|
|
DDX39A
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A
|
|
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4
|
|
DDX53
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 53
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEC1
|
deleted in esophageal cancer 1
|
|
DEFA6
|
defensin, alpha 6, Paneth cell-specific
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEK
|
DEK proto-oncogene
|
|
DEPDC1B
|
DEP domain containing 1B
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
DLG3
|
discs, large homolog 3 (Drosophila)
|
|
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DMTF1
|
cyclin D binding myb-like transcription factor 1
|
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOCK2
|
dedicator of cytokinesis 2
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPP8
|
dipeptidyl-peptidase 8
|
|
DPP9
|
dipeptidyl-peptidase 9
|
|
DRAM1
|
DNA-damage regulated autophagy modulator 1
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DSG2
|
desmoglein 2
|
|
DSG3
|
desmoglein 3
|
|
DUOX2
|
dual oxidase 2
|
|
DUOXA2
|
dual oxidase maturation factor 2
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
E2F6
|
E2F transcription factor 6
|
|
E4F1
|
E4F transcription factor 1
|
|
ECI1
|
enoyl-CoA delta isomerase 1
|
|
EDC4
|
enhancer of mRNA decapping 4
|
|
EDN1
|
endothelin 1
|
|
EDN2
|
endothelin 2
|
|
EDN3
|
endothelin 3
|
|
EDNRB
|
endothelin receptor type B
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EFNA1
|
ephrin-A1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EGR1
|
early growth response 1
|
|
EGR2
|
early growth response 2
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EID1
|
EP300 interacting inhibitor of differentiation 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2B4
|
eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF3A
|
eukaryotic translation initiation factor 3, subunit A
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EIF6
|
eukaryotic translation initiation factor 6
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EMD
|
emerin
|
|
EMILIN2
|
elastin microfibril interfacer 2
|
|
EMP3
|
epithelial membrane protein 3
|
|
EN2
|
engrailed homeobox 2
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
ENG
|
endoglin
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
ENTPD5
|
ectonucleoside triphosphate diphosphohydrolase 5
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPC1
|
enhancer of polycomb homolog 1 (Drosophila)
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB4
|
EPH receptor B4
|
|
EPHB6
|
EPH receptor B6
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
EPS8
|
epidermal growth factor receptor pathway substrate 8
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
EREG
|
epiregulin
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV1
|
ets variant 1
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXO1
|
exonuclease 1
|
|
EYA2
|
EYA transcriptional coactivator and phosphatase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FADS1
|
fatty acid desaturase 1
|
|
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase)
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCI
|
Fanconi anemia, complementation group I
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBXO32
|
F-box protein 32
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCRL5
|
Fc receptor-like 5
|
|
FCRLA
|
Fc receptor-like A
|
|
FCRLB
|
Fc receptor-like B
|
|
FDCSP
|
follicular dendritic cell secreted protein
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF4
|
fibroblast growth factor 4
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FGFRL1
|
fibroblast growth factor receptor-like 1
|
|
FH
|
fumarate hydratase
|
|
FHIT
|
fragile histidine triad
|
|
FHL1
|
four and a half LIM domains 1
|
|
FHOD1
|
formin homology 2 domain containing 1
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
|
FLCN
|
folliculin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLNA
|
filamin A, alpha
|
|
FLOT1
|
flotillin 1
|
|
FLOT2
|
flotillin 2
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMNL1
|
formin-like 1
|
|
FMR1
|
fragile X mental retardation 1
|
|
FMR1NB
|
fragile X mental retardation 1 neighbor
|
|
FN1
|
fibronectin 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXA2
|
forkhead box A2
|
|
FOXF1
|
forkhead box F1
|
|
FOXM1
|
forkhead box M1
|
|
FOXN3
|
forkhead box N3
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXP3
|
forkhead box P3
|
|
FRK
|
fyn-related Src family tyrosine kinase
|
|
FRMD6
|
FERM domain containing 6
|
|
FTH1
|
ferritin, heavy polypeptide 1
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FUT6
|
fucosyltransferase 6 (alpha (1,3) fucosyltransferase)
|
|
FXN
|
frataxin
|
|
FZD3
|
frizzled class receptor 3
|
|
G0S2
|
G0/G1 switch 2
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALC
|
galactosylceramidase
|
|
GALNT14
|
polypeptide N-acetylgalactosaminyltransferase 14
|
|
GALR1
|
galanin receptor 1
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GAS1
|
growth arrest-specific 1
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GATA6
|
GATA binding protein 6
|
|
GBP5
|
guanylate binding protein 5
|
|
GDAP1
|
ganglioside induced differentiation associated protein 1
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF2
|
growth differentiation factor 2
|
|
GGA3
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 3
|
|
GGCX
|
gamma-glutamyl carboxylase
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIPC1
|
GIPC PDZ domain containing family, member 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJD3
|
gap junction protein, delta 3, 31.9kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLO1
|
glyoxalase I
|
|
GLP2R
|
glucagon-like peptide 2 receptor
|
|
GLRX2
|
glutaredoxin 2
|
|
GLS
|
glutaminase
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNA15
|
guanine nucleotide binding protein (G protein), alpha 15 (Gq class)
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GOLM1
|
golgi membrane protein 1
|
|
GOLPH3
|
golgi phosphoprotein 3 (coat-protein)
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
|
GPC3
|
glypican 3
|
|
GPC5
|
glypican 5
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPLD1
|
glycosylphosphatidylinositol specific phospholipase D1
|
|
GPNMB
|
glycoprotein (transmembrane) nmb
|
|
GPR17
|
G protein-coupled receptor 17
|
|
GPR55
|
G protein-coupled receptor 55
|
|
GPRC5A
|
G protein-coupled receptor, class C, group 5, member A
|
|
GRAMD4
|
GRAM domain containing 4
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRN
|
granulin
|
|
GRP
|
gastrin-releasing peptide
|
|
GRPR
|
gastrin-releasing peptide receptor
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSS
|
glutathione synthetase
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H1FX
|
H1 histone family, member X
|
|
H2AFX
|
H2A histone family, member X
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAP1
|
huntingtin-associated protein 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HBB
|
hemoglobin, beta
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC8
|
histone deacetylase 8
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HECA
|
headcase homolog (Drosophila)
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HFE2
|
hemochromatosis type 2 (juvenile)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST2H3A
|
histone cluster 2, H3a
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLCS
|
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase)
|
|
HMBS
|
hydroxymethylbilane synthase
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HMOX2
|
heme oxygenase 2
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HNRNPA3
|
heterogeneous nuclear ribonucleoprotein A3
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HOXA9
|
homeobox A9
|
|
HOXA@
|
homeobox A cluster
|
|
HOXB4
|
homeobox B4
|
|
HOXB7
|
homeobox B7
|
|
HOXB9
|
homeobox B9
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B1L
|
hydroxysteroid (11-beta) dehydrogenase 1-like
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB8
|
heat shock 22kDa protein 8
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTRA3
|
HtrA serine peptidase 3
|
|
HTRA4
|
HtrA serine peptidase 4
|
|
HTT
|
huntingtin
|
|
HUNK
|
hormonally up-regulated Neu-associated kinase
|
|
HYOU1
|
hypoxia up-regulated 1
|
|
IBSP
|
integrin-binding sialoprotein
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFI44L
|
interferon-induced protein 44-like
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFITM1
|
interferon induced transmembrane protein 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL2
|
interferon, lambda 2
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGK
|
immunoglobulin kappa locus
|
|
IHH
|
indian hedgehog
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos)
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL11
|
interleukin 11
|
|
IL12B
|
interleukin 12B
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL13
|
interleukin 13
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL15
|
interleukin 15
|
|
IL18
|
interleukin 18
|
|
IL18BP
|
interleukin 18 binding protein
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL20RA
|
interleukin 20 receptor, alpha
|
|
IL20RB
|
interleukin 20 receptor beta
|
|
IL21
|
interleukin 21
|
|
IL21R
|
interleukin 21 receptor
|
|
IL22RA1
|
interleukin 22 receptor, alpha 1
|
|
IL24
|
interleukin 24
|
|
IL26
|
interleukin 26
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL32
|
interleukin 32
|
|
IL4
|
interleukin 4
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
ILK
|
integrin-linked kinase
|
|
ING1
|
inhibitor of growth family, member 1
|
|
ING2
|
inhibitor of growth family, member 2
|
|
ING4
|
inhibitor of growth family, member 4
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INHBB
|
inhibin, beta B
|
|
INHBC
|
inhibin, beta C
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSR
|
insulin receptor
|
|
INTS6
|
integrator complex subunit 6
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRS1
|
insulin receptor substrate 1
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB6
|
integrin, beta 6
|
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4
|
|
ITM2B
|
integral membrane protein 2B
|
|
JAG1
|
jagged 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JAM3
|
junctional adhesion molecule 3
|
|
JMJD1C
|
jumonji domain containing 1C
|
|
JMY
|
junction mediating and regulatory protein, p53 cofactor
|
|
JUN
|
jun proto-oncogene
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNK5
|
potassium channel, two pore domain subfamily K, member 5
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDM2A
|
lysine (K)-specific demethylase 2A
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA0430
|
KIAA0430
|
|
KIAA1524
|
KIAA1524
|
|
KIDINS220
|
kinase D-interacting substrate, 220kDa
|
|
KIF14
|
kinesin family member 14
|
|
KIN
|
Kin17 DNA and RNA binding protein
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT1
|
keratin 1, type II
|
|
KRT8
|
keratin 8, type II
|
|
KRT81
|
keratin 81, type II
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LACRT
|
lacritin
|
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1
|
|
LAMC2
|
laminin, gamma 2
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS2
|
lectin, galactoside-binding, soluble, 2
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LGALS4
|
lectin, galactoside-binding, soluble, 4
|
|
LGMN
|
legumain
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LHX4
|
LIM homeobox 4
|
|
LHX8
|
LIM homeobox 8
|
|
LIMK2
|
LIM domain kinase 2
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LMNA
|
lamin A/C
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LOX
|
lysyl oxidase
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPAR2
|
lysophosphatidic acid receptor 2
|
|
LPAR3
|
lysophosphatidic acid receptor 3
|
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LRG1
|
leucine-rich alpha-2-glycoprotein 1
|
|
LRIG3
|
leucine-rich repeats and immunoglobulin-like domains 3
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP1B
|
low density lipoprotein receptor-related protein 1B
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRC26
|
leucine rich repeat containing 26
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LSINCT5
|
long stress-induced non-coding transcript 5
|
|
LST1
|
leukocyte specific transcript 1
|
|
LTF
|
lactotransferrin
|
|
LUM
|
lumican
|
|
LXN
|
latexin
|
|
LY75
|
lymphocyte antigen 75
|
|
M6PR
|
mannose-6-phosphate receptor (cation dependent)
|
|
MACC1
|
metastasis associated in colon cancer 1
|
|
MACF1
|
microtubule-actin crosslinking factor 1
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MADD
|
MAP-kinase activating death domain
|
|
MAF1
|
MAF1 homolog (S. cerevisiae)
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEB1
|
melanoma antigen family B1
|
|
MAGEB2
|
melanoma antigen family B2
|
|
MAGED1
|
melanoma antigen family D1
|
|
MAGT1
|
magnesium transporter 1
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene)
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAP3K9
|
mitogen-activated protein kinase kinase kinase 9
|
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
MAPK13
|
mitogen-activated protein kinase 13
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAST1
|
microtubule associated serine/threonine kinase 1
|
|
MAST2
|
microtubule associated serine/threonine kinase 2
|
|
MAT1A
|
methionine adenosyltransferase I, alpha
|
|
MATK
|
megakaryocyte-associated tyrosine kinase
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBOAT4
|
membrane bound O-acyltransferase domain containing 4
|
|
MBP
|
myelin basic protein
|
|
MBTPS1
|
membrane-bound transcription factor peptidase, site 1
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCTS1
|
malignant T cell amplified sequence 1
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MED1
|
mediator complex subunit 1
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
MEIS1
|
Meis homeobox 1
|
|
MELK
|
maternal embryonic leucine zipper kinase
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFI2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5
|
|
MGAT3
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGLL
|
monoglyceride lipase
|
|
MIA3
|
melanoma inhibitory activity family, member 3
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR1-1
|
microRNA 1-1
|
|
MIR1-2
|
microRNA 1-2
|
|
MIR100
|
microRNA 100
|
|
MIR103A1
|
microRNA 103a-1
|
|
MIR103A2
|
microRNA 103a-2
|
|
MIR106B
|
microRNA 106b
|
|
MIR107
|
microRNA 107
|
|
MIR10A
|
microRNA 10a
|
|
MIR10B
|
microRNA 10b
|
|
MIR122
|
microRNA 122
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR127
|
microRNA 127
|
|
MIR128-1
|
microRNA 128-1
|
|
MIR128-2
|
microRNA 128-2
|
|
MIR129-1
|
microRNA 129-1
|
|
MIR129-2
|
microRNA 129-2
|
|
MIR130A
|
microRNA 130a
|
|
MIR133A1
|
microRNA 133a-1
|
|
MIR133A2
|
microRNA 133a-2
|
|
MIR133B
|
microRNA 133b
|
|
MIR137
|
microRNA 137
|
|
MIR141
|
microRNA 141
|
|
MIR142
|
microRNA 142
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146B
|
microRNA 146b
|
|
MIR148A
|
microRNA 148a
|
|
MIR149
|
microRNA 149
|
|
MIR152
|
microRNA 152
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR182
|
microRNA 182
|
|
MIR191
|
microRNA 191
|
|
MIR192
|
microRNA 192
|
|
MIR194-1
|
microRNA 194-1
|
|
MIR195
|
microRNA 195
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR198
|
microRNA 198
|
|
MIR199A1
|
microRNA 199a-1
|
|
MIR199A2
|
microRNA 199a-2
|
|
MIR19A
|
microRNA 19a
|
|
MIR200B
|
microRNA 200b
|
|
MIR200C
|
microRNA 200c
|
|
MIR203A
|
microRNA 203a
|
|
MIR205
|
microRNA 205
|
|
MIR206
|
microRNA 206
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR211
|
microRNA 211
|
|
MIR215
|
microRNA 215
|
|
MIR218-1
|
microRNA 218-1
|
|
MIR22
|
microRNA 22
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR223
|
microRNA 223
|
|
MIR224
|
microRNA 224
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR26B
|
microRNA 26b
|
|
MIR27A
|
microRNA 27a
|
|
MIR28
|
microRNA 28
|
|
MIR29A
|
microRNA 29a
|
|
MIR30A
|
microRNA 30a
|
|
MIR30D
|
microRNA 30d
|
|
MIR31
|
microRNA 31
|
|
MIR335
|
microRNA 335
|
|
MIR338
|
microRNA 338
|
|
MIR34A
|
microRNA 34a
|
|
MIR372
|
microRNA 372
|
|
MIR373
|
microRNA 373
|
|
MIR375
|
microRNA 375
|
|
MIR378A
|
microRNA 378a
|
|
MIR433
|
microRNA 433
|
|
MIR4723
|
microRNA 4723
|
|
MIR497
|
microRNA 497
|
|
MIR5000
|
microRNA 5000
|
|
MIR5009
|
microRNA 5009
|
|
MIR548M
|
microRNA 548m
|
|
MIR552
|
microRNA 552
|
|
MIR573
|
microRNA 573
|
|
MIR612
|
microRNA 612
|
|
MIR633
|
microRNA 633
|
|
MIR663A
|
microRNA 663a
|
|
MIR7-1
|
microRNA 7-1
|
|
MIR9-1
|
microRNA 9-1
|
|
MIR9-2
|
microRNA 9-2
|
|
MIR93
|
microRNA 93
|
|
MIR99A
|
microRNA 99a
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MIRLET7A2
|
microRNA let-7a-2
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MKRN2
|
makorin ring finger protein 2
|
|
MLH1
|
mutL homolog 1
|
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
|
MMAB
|
methylmalonic aciduria (cobalamin deficiency) cblB type
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPST
|
mercaptopyruvate sulfurtransferase
|
|
MR1
|
major histocompatibility complex, class I-related
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MRRF
|
mitochondrial ribosome recycling factor
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSLN
|
mesothelin
|
|
MSN
|
moesin
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MT-ND5
|
NADH dehydrogenase, subunit 5 (complex I)
|
|
MT-TH
|
tRNA
|
|
MT-TM
|
tRNA
|
|
MTA1
|
metastasis associated 1
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTSS1
|
metastasis suppressor 1
|
|
MTUS1
|
microtubule associated tumor suppressor 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC17
|
mucin 17, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUTYH
|
mutY homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYCT1
|
myc target 1
|
|
MYLIP
|
myosin regulatory light chain interacting protein
|
|
MYT1L
|
myelin transcription factor 1-like
|
|
MZF1
|
myeloid zinc finger 1
|
|
NAA16
|
N(alpha)-acetyltransferase 16, NatA auxiliary subunit
|
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing
|
|
NANOG
|
Nanog homeobox
|
|
NBN
|
nibrin
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NDUFS3
|
NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase)
|
|
NDUFS6
|
NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase)
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NELFB
|
negative elongation factor complex member B
|
|
NES
|
nestin
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIB
|
nuclear factor I/B
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NHEJ1
|
nonhomologous end-joining factor 1
|
|
NID1
|
nidogen 1
|
|
NID2
|
nidogen 2 (osteonidogen)
|
|
NKAIN2
|
Na+/K+ transporting ATPase interacting 2
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NME2
|
NME/NM23 nucleoside diphosphate kinase 2
|
|
NMU
|
neuromedin U
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOX1
|
NADPH oxidase 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPTX1
|
neuronal pentraxin I
|
|
NPTX2
|
neuronal pentraxin II
|
|
NPTXR
|
neuronal pentraxin receptor
|
|
NPY
|
neuropeptide Y
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR6A1
|
nuclear receptor subfamily 6, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRF1
|
nuclear respiratory factor 1
|
|
NRG1
|
neuregulin 1
|
|
NRP1
|
neuropilin 1
|
|
NSUN2
|
NOP2/Sun RNA methyltransferase family, member 2
|
|
NTF3
|
neurotrophin 3
|
|
NTF4
|
neurotrophin 4
|
|
NTN1
|
netrin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
NUP214
|
nucleoporin 214kDa
|
|
ODAM
|
odontogenic, ameloblast asssociated
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OPRL1
|
opiate receptor-like 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
OSM
|
oncostatin M
|
|
OTX1
|
orthodenticle homeobox 1
|
|
OTX2
|
orthodenticle homeobox 2
|
|
OXCT1
|
3-oxoacid CoA transferase 1
|
|
OXSR1
|
oxidative stress responsive 1
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
OXTR
|
oxytocin receptor
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PAQR5
|
progestin and adipoQ receptor family member V
|
|
PAQR7
|
progestin and adipoQ receptor family member VII
|
|
PAQR8
|
progestin and adipoQ receptor family member VIII
|
|
PARG
|
poly (ADP-ribose) glycohydrolase
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX3
|
paired box 3
|
|
PAX4
|
paired box 4
|
|
PAX5
|
paired box 5
|
|
PCDH10
|
protocadherin 10
|
|
PCGEM1
|
PCGEM1, prostate-specific transcript (non-protein coding)
|
|
PCK2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK1
|
proprotein convertase subtilisin/kexin type 1
|
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD2
|
programmed cell death 2
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDF
|
peptide deformylase (mitochondrial)
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFC
|
platelet derived growth factor C
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDLIM5
|
PDZ and LIM domain 5
|
|
PDPN
|
podoplanin
|
|
PDSS2
|
prenyl (decaprenyl) diphosphate synthase, subunit 2
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEG10
|
paternally expressed 10
|
|
PEPD
|
peptidase D
|
|
PER2
|
period circadian clock 2
|
|
PERP
|
PERP, TP53 apoptosis effector
|
|
PEX26
|
peroxisomal biogenesis factor 26
|
|
PEX5
|
peroxisomal biogenesis factor 5
|
|
PF4
|
platelet factor 4
|
|
PFDN4
|
prefoldin subunit 4
|
|
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
|
|
PFN1
|
profilin 1
|
|
PGAM1
|
phosphoglycerate mutase 1 (brain)
|
|
PGF
|
placental growth factor
|
|
PGK1
|
phosphoglycerate kinase 1
|
|
PGP
|
phosphoglycolate phosphatase
|
|
PHF19
|
PHD finger protein 19
|
|
PHIP
|
pleckstrin homology domain interacting protein
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PHRF1
|
PHD and ring finger domains 1
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PIAS4
|
protein inhibitor of activated STAT, 4
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
|
PIK3C2B
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM3
|
Pim-3 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PIWIL1
|
piwi-like RNA-mediated gene silencing 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PKP2
|
plakophilin 2
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAC8
|
placenta-specific 8
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLEK2
|
pleckstrin 2
|
|
PLK1
|
polo-like kinase 1
|
|
PLXDC1
|
plexin domain containing 1
|
|
PLXNB1
|
plexin B1
|
|
PML
|
promyelocytic leukemia
|
|
PNPT1
|
polyribonucleotide nucleotidyltransferase 1
|
|
PODXL
|
podocalyxin-like
|
|
POGLUT1
|
protein O-glucosyltransferase 1
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLR1B
|
polymerase (RNA) I polypeptide B, 128kDa
|
|
POLR3B
|
polymerase (RNA) III (DNA directed) polypeptide B
|
|
POLR3K
|
polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa
|
|
POT1
|
protection of telomeres 1
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
POU3F2
|
POU class 3 homeobox 2
|
|
POU4F2
|
POU class 4 homeobox 2
|
|
POU4F3
|
POU class 4 homeobox 3
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
POU6F1
|
POU class 6 homeobox 1
|
|
PPAPDC1B
|
phosphatidic acid phosphatase type 2 domain containing 1B
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPM1F
|
protein phosphatase, Mg2+/Mn2+ dependent, 1F
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PPP1R26
|
protein phosphatase 1, regulatory subunit 26
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha
|
|
PPP3CB
|
protein phosphatase 3, catalytic subunit, beta isozyme
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX5
|
peroxiredoxin 5
|
|
PRDX6
|
peroxiredoxin 6
|
|
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCDBP
|
protein kinase C, delta binding protein
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRKG2
|
protein kinase, cGMP-dependent, type II
|
|
PRLR
|
prolactin receptor
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PRNP
|
prion protein
|
|
PROK1
|
prokineticin 1
|
|
PROKR1
|
prokineticin receptor 1
|
|
PROM1
|
prominin 1
|
|
PROX1
|
prospero homeobox 1
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PRPF8
|
pre-mRNA processing factor 8
|
|
PRR5
|
proline rich 5 (renal)
|
|
PRRX1
|
paired related homeobox 1
|
|
PRSS8
|
protease, serine, 8
|
|
PSAP
|
prosaposin
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSMB5
|
proteasome (prosome, macropain) subunit, beta type, 5
|
|
PSMB7
|
proteasome (prosome, macropain) subunit, beta type, 7
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTENP1
|
phosphatase and tensin homolog pseudogene 1 (functional)
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGR1
|
prostaglandin reductase 1
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTN
|
pleiotrophin
|
|
PTOV1
|
prostate tumor overexpressed 1
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN23
|
protein tyrosine phosphatase, non-receptor type 23
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTRF
|
polymerase I and transcript release factor
|
|
PTX3
|
pentraxin 3, long
|
|
PVR
|
poliovirus receptor
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
PXN
|
paxillin
|
|
PYCARD
|
PYD and CARD domain containing
|
|
PYGO2
|
pygopus family PHD finger 2
|
|
RAB27B
|
RAB27B, member RAS oncogene family
|
|
RAB37
|
RAB37, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG2
|
recombination activating gene 2
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES3
|
retinoic acid receptor responder (tazarotene induced) 3
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF10
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 10
|
|
RB1
|
retinoblastoma 1
|
|
RBBP7
|
retinoblastoma binding protein 7
|
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBM14
|
RNA binding motif protein 14
|
|
RCHY1
|
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase
|
|
RCN1
|
reticulocalbin 1, EF-hand calcium binding domain
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
RECQL4
|
RecQ protein-like 4
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
REPS1
|
RALBP1 associated Eps domain containing 1
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RGMA
|
repulsive guidance molecule family member a
|
|
RGMB
|
repulsive guidance molecule family member b
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOC
|
ras homolog family member C
|
|
RHOD
|
ras homolog family member D
|
|
RHOXF2
|
Rhox homeobox family, member 2
|
|
RIC3
|
RIC3 acetylcholine receptor chaperone
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIN1
|
Ras and Rab interactor 1
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
|
RLN1
|
relaxin 1
|
|
RLN2
|
relaxin 2
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNASET2
|
ribonuclease T2
|
|
RND3
|
Rho family GTPase 3
|
|
RNF113A
|
ring finger protein 113A
|
|
RNF138
|
ring finger protein 138, E3 ubiquitin protein ligase
|
|
RNF14
|
ring finger protein 14
|
|
RNU4ATAC
|
RNA, U4atac small nuclear (U12-dependent splicing)
|
|
ROBO4
|
roundabout, axon guidance receptor, homolog 4 (Drosophila)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RORA
|
RAR-related orphan receptor A
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPL10
|
ribosomal protein L10
|
|
RPS19BP1
|
ribosomal protein S19 binding protein 1
|
|
RPS2
|
ribosomal protein S2
|
|
RPS6KA6
|
ribosomal protein S6 kinase, 90kDa, polypeptide 6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S100A11
|
S100 calcium binding protein A11
|
|
S100A14
|
S100 calcium binding protein A14
|
|
S100B
|
S100 calcium binding protein B
|
|
S100P
|
S100 calcium binding protein P
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAMD11
|
sterile alpha motif domain containing 11
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SAT2
|
spermidine/spermine N1-acetyltransferase family member 2
|
|
SATB1
|
SATB homeobox 1
|
|
SBF1
|
SET binding factor 1
|
|
SCAMP1
|
secretory carrier membrane protein 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SDC4
|
syndecan 4
|
|
SDCBP
|
syndecan binding protein (syntenin)
|
|
SDPR
|
serum deprivation response
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
|
SEMG1
|
semenogelin I
|
|
SEP15
|
15 kDa selenoprotein
|
|
SEPT1
|
septin 1
|
|
SEPW1
|
selenoprotein W, 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
|
SERTAD2
|
SERTA domain containing 2
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETDB1
|
SET domain, bifurcated 1
|
|
SFN
|
stratifin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH2D3A
|
SH2 domain containing 3A
|
|
SH2D3C
|
SH2 domain containing 3C
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SIX1
|
SIX homeobox 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC18A3
|
solute carrier family 18 (vesicular acetylcholine transporter), member 3
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC22A13
|
solute carrier family 22 (organic anion/urate transporter), member 13
|
|
SLC24A2
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2
|
|
SLC25A19
|
solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19
|
|
SLC25A43
|
solute carrier family 25, member 43
|
|
SLC26A1
|
solute carrier family 26 (anion exchanger), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC30A1
|
solute carrier family 30 (zinc transporter), member 1
|
|
SLC30A10
|
solute carrier family 30, member 10
|
|
SLC31A2
|
solute carrier family 31 (copper transporter), member 2
|
|
SLC38A3
|
solute carrier family 38, member 3
|
|
SLC39A1
|
solute carrier family 39 (zinc transporter), member 1
|
|
SLC44A4
|
solute carrier family 44, member 4
|
|
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC5A8
|
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8
|
|
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLCO1A2
|
solute carrier organic anion transporter family, member 1A2
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD6
|
SMAD family member 6
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMC2
|
structural maintenance of chromosomes 2
|
|
SMC4
|
structural maintenance of chromosomes 4
|
|
SMG1
|
SMG1 phosphatidylinositol 3-kinase-related kinase
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI1P1
|
snail family zinc finger 1 pseudogene 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNAP47
|
synaptosomal-associated protein, 47kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SND1
|
staphylococcal nuclease and tudor domain containing 1
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOCS4
|
suppressor of cytokine signaling 4
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORD
|
sorbitol dehydrogenase
|
|
SORT1
|
sortilin 1
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX14
|
SRY (sex determining region Y)-box 14
|
|
SOX15
|
SRY (sex determining region Y)-box 15
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP140
|
SP140 nuclear body protein
|
|
SP4
|
Sp4 transcription factor
|
|
SPA17
|
sperm autoantigenic protein 17
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINK2
|
serine peptidase inhibitor, Kazal type 2 (acrosin-trypsin inhibitor)
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPN
|
sialophorin
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila)
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPSB2
|
splA/ryanodine receptor domain and SOCS box containing 2
|
|
SPTAN1
|
spectrin, alpha, non-erythrocytic 1
|
|
SPTLC1
|
serine palmitoyltransferase, long chain base subunit 1
|
|
SPTLC3
|
serine palmitoyltransferase, long chain base subunit 3
|
|
SQSTM1
|
sequestosome 1
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRGN
|
serglycin
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SSTR1
|
somatostatin receptor 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR3
|
somatostatin receptor 3
|
|
SSUH2
|
ssu-2 homolog (C. elegans)
|
|
SSX4
|
synovial sarcoma, X breakpoint 4
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST3GAL3
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 3
|
|
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
|
|
ST3GAL6
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
|
|
ST6GALNAC2
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
|
|
ST7
|
suppression of tumorigenicity 7
|
|
ST8SIA2
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
|
|
ST8SIA4
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STK26
|
serine/threonine protein kinase 26
|
|
STMN1
|
stathmin 1
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
STYK1
|
serine/threonine/tyrosine kinase 1
|
|
SUGT1
|
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae)
|
|
SULF2
|
sulfatase 2
|
|
SUMF1
|
sulfatase modifying factor 1
|
|
SURF1
|
surfeit 1
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
SYK
|
spleen tyrosine kinase
|
|
SYNPO2
|
synaptopodin 2
|
|
SYTL1
|
synaptotagmin-like 1
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TAGLN
|
transgelin
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBP
|
TATA box binding protein
|
|
TBPL2
|
TATA box binding protein like 2
|
|
TBX1
|
T-box 1
|
|
TBX21
|
T-box 21
|
|
TBX3
|
T-box 3
|
|
TCEB1
|
transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C)
|
|
TCF3
|
transcription factor 3
|
|
TCF4
|
transcription factor 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TCTA
|
T-cell leukemia translocation altered
|
|
TDP2
|
tyrosyl-DNA phosphodiesterase 2
|
|
TEC
|
tec protein tyrosine kinase
|
|
TERC
|
telomerase RNA component
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TEX101
|
testis expressed 101
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFDP3
|
transcription factor Dp family, member 3
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFF1
|
trefoil factor 1
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFR2
|
transferrin receptor 2
|
|
TFRC
|
transferrin receptor
|
|
TG
|
thyroglobulin
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TGIF1
|
TGFB-induced factor homeobox 1
|
|
TGM2
|
transglutaminase 2
|
|
TGM4
|
transglutaminase 4
|
|
TH
|
tyrosine hydroxylase
|
|
THBS2
|
thrombospondin 2
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIAM2
|
T-cell lymphoma invasion and metastasis 2
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIPE1
|
TNF alpha induced protein 8 like 1
|
|
TIPE2
|
TNF alpha induced protein 8 like 2
|
|
TIPRL
|
TOR signaling pathway regulator
|
|
TJP1
|
tight junction protein 1
|
|
TLN1
|
talin 1
|
|
TLR10
|
toll-like receptor 10
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TLX2
|
T-cell leukemia homeobox 2
|
|
TMBIM6
|
transmembrane BAX inhibitor motif containing 6
|
|
TMED1
|
transmembrane emp24 protein transport domain containing 1
|
|
TMED2
|
transmembrane emp24 domain trafficking protein 2
|
|
TMEM184C
|
transmembrane protein 184C
|
|
TMEM55B
|
transmembrane protein 55B
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMSB10
|
thymosin beta 10
|
|
TMSB15A
|
thymosin beta 15a
|
|
TMSB15B
|
thymosin beta 15B
|
|
TMSB4Y
|
thymosin beta 4, Y-linked
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial)
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF19
|
tumor necrosis factor receptor superfamily, member 19
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOP2B
|
topoisomerase (DNA) II beta 180kDa
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP53BP2
|
tumor protein p53 binding protein 2
|
|
TP53INP1
|
tumor protein p53 inducible nuclear protein 1
|
|
TP73
|
tumor protein p73
|
|
TP73-AS1
|
TP73 antisense RNA 1
|
|
TPI1
|
triosephosphate isomerase 1
|
|
TPK1
|
thiamin pyrophosphokinase 1
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRAP1
|
TNF receptor-associated protein 1
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRNAG1
|
tRNA glycine1 (anticodon CCC)
|
|
TRO
|
trophinin
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHZ2
|
teashirt zinc finger homeobox 2
|
|
TSHZ3
|
teashirt zinc finger homeobox 3
|
|
TTC7B
|
tetratricopeptide repeat domain 7B
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUSC3
|
tumor suppressor candidate 3
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
|
UBE2Q1
|
ubiquitin-conjugating enzyme E2Q family member 1
|
|
UBE2Q2
|
ubiquitin-conjugating enzyme E2Q family member 2
|
|
UBE2T
|
ubiquitin-conjugating enzyme E2T
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
UEVLD
|
UEV and lactate/malate dehyrogenase domains
|
|
UHMK1
|
U2AF homology motif (UHM) kinase 1
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
ULBP2
|
UL16 binding protein 2
|
|
ULK2
|
unc-51 like autophagy activating kinase 2
|
|
UNC5B
|
unc-5 homolog B (C. elegans)
|
|
UNG
|
uracil-DNA glycosylase
|
|
USP24
|
ubiquitin specific peptidase 24
|
|
USP5
|
ubiquitin specific peptidase 5 (isopeptidase T)
|
|
UTS2R
|
urotensin 2 receptor
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VCAN
|
versican
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFB
|
vascular endothelial growth factor B
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VGF
|
VGF nerve growth factor inducible
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VIP
|
vasoactive intestinal peptide
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
|
VIPR2
|
vasoactive intestinal peptide receptor 2
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VPS4A
|
vacuolar protein sorting 4 homolog A (S. cerevisiae)
|
|
VPS4B
|
vacuolar protein sorting 4 homolog B (S. cerevisiae)
|
|
VRK2
|
vaccinia related kinase 2
|
|
VSNL1
|
visinin-like 1
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
VTN
|
vitronectin
|
|
VWF
|
von Willebrand factor
|
|
WBSCR22
|
Williams Beuren syndrome chromosome region 22
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WHSC1L1
|
Wolf-Hirschhorn syndrome candidate 1-like 1
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT10B
|
wingless-type MMTV integration site family, member 10B
|
|
WNT2B
|
wingless-type MMTV integration site family, member 2B
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT5B
|
wingless-type MMTV integration site family, member 5B
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WNT8A
|
wingless-type MMTV integration site family, member 8A
|
|
WNT8B
|
wingless-type MMTV integration site family, member 8B
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XAF1
|
XIAP associated factor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPO1
|
exportin 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YBX3
|
Y box binding protein 3
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
ZBTB33
|
zinc finger and BTB domain containing 33
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZHX2
|
zinc fingers and homeoboxes 2
|
|
ZIC1
|
Zic family member 1
|
|
ZMIZ1
|
zinc finger, MIZ-type containing 1
|
|
ZNF148
|
zinc finger protein 148
|
|
ZNF195
|
zinc finger protein 195
|
|
ZNF217
|
zinc finger protein 217
|
|
ZNF24
|
zinc finger protein 24
|
|
ZNF331
|
zinc finger protein 331
|
|
ZNF350
|
zinc finger protein 350
|
|
ZNF461
|
zinc finger protein 461
|
